Common Infections Following Lung Transplantation

The lungs are the only transplanted organ in direct contact with the ‘outside world’. Infection is a significant cause of morbidity and mortality in lung transplantation. Early accurate diagnosis and optimal management is essential to prevent short and long term complications. Bacteria, including Mycobacteria and Nocardia, viruses and fungi are common pathogens. Organisms may be present in the recipient prior to transplantation, transmitted with the donor lungs or acquired after transplantation. The degree of immunosuppression and the routine use of antimicrobial prophylaxis alters the pattern of post-transplant infections.

• Publication year

  2018

• Venue

  Essentials in Lung Transplantation

• Publication date

  2018-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-90933-2_15PMCID 7121478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Disseminated actinomycetoma due to Nocardia wallacei

  2018cited by this paper
• Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy

  2017cited by this paper
• A review of the microbiological problems and biofilms associated with Mycobacterium chimaera in heater cooler units used for cardiopulmonary bypass

  2017cited by this paper
• Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

  2017cited by this paper
• Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

  2017cited by this paper
• A review of the microbiological problems and biofilms associated with Mycobacterium chimaera in heater cooler units used for cardiopulmonary bypass

  2017cited by this paper
• British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

  2017cited by this paper
• Human Herpesvirus

  2016cited by this paper
• The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary.

  2016cited by this paper
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

  2016cited by this paper
• Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

  2016cited by this paper
• Invasive mold infections in lung and heart‐lung transplant recipients: Stanford University experience

  2015cited by this paper
• Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole antifungal prophylaxis

  2015cited by this paper
• Scedosporium Apiospermum Infection after Near-drowning

  2015cited by this paper
• Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis.

  2015cited by this paper
• Respiratory metapneumoviral infection without co-infection in association with acute and chronic lung allograft dysfunction

  2015cited by this paper
• Mycobacterial infections in solid organ transplant recipients.

  2014cited by this paper
• Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients

  2014cited by this paper
• Antifungal prophylaxis in lung transplantation.

  2014cited by this paper
• Paediatric human metapneumovirus infection: epidemiology, prevention and therapy.

  2014cited by this paper
• Nocardia Infections in Solid Organ Transplantation

  2013cited by this paper
• Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.

  2013cited by this paper
• non-tuberculous mycobacterial infection in non-AIDS immunocompromised patients: a case-controlled comparison with immunocompetent patients

  2013cited by this paper
• Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species

  2013cited by this paper
• Mycobacterium tuberculosis Infections in Solid Organ Transplantation

  2013cited by this paper
• Endemic Fungal Infections in Solid Organ Transplantation

  2013cited by this paper
• What Is the Impact of Hypogammaglobulinemia on the Rate of Infections and Survival in Solid Organ Transplantation? A Meta‐Analysis

  2013cited by this paper
• Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study

  2013cited by this paper
• Lung transplant outcomes in cystic fibrosis patients with pre‐operative Mycobacterium abscessus respiratory infections

  2013cited by this paper
• The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement

  2012cited by this paper
• A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation: A Sequential Cohort Analysis

  2012cited by this paper
• Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes.

  2012cited by this paper
• A multicenter evaluation of tests for diagnosis of histoplasmosis.

  2011cited by this paper
• Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

  2011cited by this paper
• Nontuberculous mycobacteria infection in solid organ transplant recipients

  2011cited by this paper
• A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

  2011cited by this paper
• CT findings of pulmonary nocardiosis.

  2011cited by this paper
• aN OutBreaK Of Pneumocystis jirovecii PNeumONIa wIth ONe PredOmINaNt GeNOtyPe IN reNaL traNsPLaNt reCIPIeNts: INterhumaN traNsmIssION Or a COmmON eNVIrONmeNtaL sOurCe?

  2011cited by this paper
• Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs.

  2011cited by this paper
• The Changing Microbial Epidemiology in Cystic Fibrosis

  2010cited by this paper
• Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

  2010cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010.

  2010cited by this paper
• Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

  2010cited by this paper
• Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.

  2010cited by this paper
• Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort.

  2009cited by this paper
• Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.

  2009cited by this paper
• Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.

  2009cited by this paper
• Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome

  2009cited by this paper
• Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

  2009cited by this paper
• Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007

  2008cited by this paper
• Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.

  2008cited by this paper
• Infectious complications associated with the use of rituximab for ABO‐incompatible and positive cross‐match renal transplant recipients

  2007cited by this paper
• Invasive adenoviral infections in T‐cell‐depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir

  2007cited by this paper
• Update on Immunizations in Solid Organ Transplant Recipients: What Clinicians Need to Know

  2007cited by this paper
• Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.

  2007cited by this paper
• Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases

  2007cited by this paper
• Scedosporium apiospermum infection after near‐drowning

  2007cited by this paper
• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

  2007cited by this paper
• Human herpesvirus-6 and -7 after lung and heart-lung transplantation.

  2007cited by this paper
• Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.

  2007cited by this paper
• Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.

  2007cited by this paper
• An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

  2007cited by this paper
• Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.

  2006cited by this paper
• Chronic rhinoviral infection in lung transplant recipients.

  2006cited by this paper
• A Prospective Survey of Human Herpesvirus-6 Primary Infection in Solid Organ Transplant Recipients

  2006cited by this paper
• Effect of Ribavirin and Glucocorticoid Treatment in a Mouse Model of Human Metapneumovirus Infection

  2006cited by this paper
• Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy

  2006cited by this paper
• Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic Fibrosis

  2006cited by this paper
• Gastrointestinal Zygomycosis Complicating Heart and Lung Transplantation in a Patient with Eisenmenger’s Syndrome

  2005cited by this paper
• Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients

  2005cited by this paper
• Cellulitis caused by Cryptococcus neoformans in a lung transplant recipient.

  2005cited by this paper
• Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005.

  2005cited by this paper
• Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.

  2005cited by this paper
• Clinical Impact of Community‐Acquired Respiratory Viruses on Bronchiolitis Obliterans After Lung Transplant

  2005cited by this paper
• Pneumocystis carinii: has the name really been changed?

  2005cited by this paper
• An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.

  2005cited by this paper
• Has the name really been changed? It has for most researchers.

  2005cited by this paper
• Influenza vaccine antibody responses in lung transplant recipients.

  2004cited by this paper
• Influenza Vaccine Antibody Responses in Lung Transplant Recipients

  2004cited by this paper
• Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients

  2004cited by this paper
• Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.

  2003cited by this paper
• Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.

  2003cited by this paper
• Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro.

  2003cited by this paper
• Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case–control study

  2003cited by this paper
• Human herpesvirus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya.

  2003cited by this paper
• Clinical experience with linezolid for the treatment of nocardia infection.

  2003cited by this paper
• Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.

  2002cited by this paper
• Influenza Virus Infection in Adult Solid Organ Transplant Recipients

  2002cited by this paper
• Seroprevalence of HSV-1 and HSV-2 infection in the general French population

  2002cited by this paper
• Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies

  2001cited by this paper
• Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature.

  2001cited by this paper
• Nosocomial Mycobacterium chelonae Infection in Laparoscopic Surgery

  2001cited by this paper
• Significant post‐transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?

  2000cited by this paper
• Anastomotic infections in lung transplant recipients.

  2000cited by this paper
• The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes

  2000cited by this paper
• Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients.

  2000cited by this paper
• The spectrum of mycobacterial infection after lung transplantation.

  1999cited by this paper
• In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole

  1999cited by this paper
• Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.

  1998cited by this paper
• Community respiratory viral infection in adult lung transplant recipients.

  1998cited by this paper

• Respiratory infections in lung transplant recipients

  2025cites this paper
• Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study

  2023influential citation